Gestational Age and Cell Viability Determine the Effect of Frozen Storage on Human Fetal Hematopoietic Progenitor Cell Preparations

Fetal Diagnosis and Therapy

Volumn 11, Issue 6, 1996, Pages 427-432

  Anderson, E M ^a   Jones, D R E ^a   Liu, D T Y ^b   Evans, A A ^a  

^a Queens Medical Centre   (Ukraine)

^b NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

Fetal hematopoiesis; Stem cell transplantation; Tissue bank

Indexed keywords

CD34 ANTIGEN;

ARTICLE; CELL COUNT; CELL TRANSPLANTATION; CELL VIABILITY; CRYOPRESERVATION; FETUS; FETUS CELL; FETUS LIVER; FETUS SURGERY; FREEZING; GESTATIONAL AGE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; THAWING;

EID: 0030447451     PISSN: 10153837     EISSN: 14219964     Source Type: Journal    
DOI: 10.1159/000264360     Document Type: Article

References (18)

1. Jones DRE, Anderson EM, Evans AA, Liu DTY: Long-term storage of human haematopoietic progenitor cells and their subsequent reconstitution. Implications for in utero transplantation. Bone Marrow Transplant 1995:16:298-301.
2. Cowan MJ. Golbus M: In utero hematopoietic stem cell transplants for inherited diseases. Am J Pediatr He-matol Oncol 1994;16:35-42.
3. Wcstgren M. Ringden O: Fetal to fetal transplantation. Acta Obstet Gynecol Scand 1994:73:371-372.
4. Ek S, Ringden O, Markling L, Wcstgren M: Immunological capacity of human fetal liver cells. Bone Marrow Transplant 1994:14:9-14.
5. Liu DTY. Bui T-H: Fetal therapy: Ethical, legal and medical considerations. Curr Opin Obstet Gynaecol 1994;4:160-165.
6. Zanjani ED, Ascensao JL, Tavassoli M: Liver-derived fetal hematopoietic stem cells selectively and preferentially home to the fetal bone marrow. Blood 1993:81:399-404.
7. Westgrcn M, Ek S, Bui T-H, et al: Establishment of a tissue bank for fetal stem cell transplantation. Acta Obstet Gynecol Scand 1994:73: 385-388.
8. Liu DTY: Fetal tissue banking: The right time is now. Br J Obstet Gynaecol 1994:101:1031-1032.
9. Polkinghornc J: Review of the Guidelines on the Research Use of Fetuses and Fetal Material. HMSO. London, 1989.
10. Department of Health: Guidance on the Use of Fetal Tissue for Research. Diagnosis and Therapy. London. Department of Health. 1995.
11. Spitz IM, Bardin CW: Clinical pharmacology of RU486: An antiprogcs-tin and antiglucocorticoid. Contraception 1993;48:403-444.
12. Evans AA, Anderson EM, Liu DTY, Jones DRE: Fetal tissue retrieval using the antiprogcstinc RU486. In preparation.
13. Rosillo MC, Ortuno F, Rivera J, Moraleda JM, Vicente V: Cryoprc-scrvation modifies flow-cytometric analysis of hemopoietic cells. Vox Sang 1995:68:210-214.
14. Ek S, Ringden O, Markling I, et al: Effects of cryopreservation on subsets of fetal liver cells. Bone Marrow Transplant 1993:11:395-398.
15. Lansdorp PM, Dragowska W, Thomas TE, Little M-T, Mavani H: Age-related decline in proliferative potential of purified stem cell candidates. Blood Cells 1994:20:376-381.
16. Lansdorp PM: Telomere length and proliferation potential of hematopoietic stem cells. J Cell Sci 1995: 108:1-6.
17. De Bruyn C. Dclforge A. Bron D. et al: Comparison of the coexpression of CD38. CD33 and HLA-DR antigens on CD34+ purified cells from human cord blood and bone marrow. Stem Cells 1995:13:281-288.
18. Gale RP: Development of the immune system in the human fetal liver. Thymus 1987:10:45-56.